Eupraxia Pharmaceuticals Inc. (EPRX) vs Treace Medical Concepts, Inc. (TMCI)

A side-by-side comparison of Eupraxia Pharmaceuticals Inc. and Treace Medical Concepts, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Eupraxia Pharmaceuticals Inc. logo
EPRX
Eupraxia Pharmaceuticals Inc.
$259M
$7.74HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Treace Medical Concepts, Inc. logo
TMCI
Treace Medical Concepts, Inc.
$259M
$4.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — EPRX vs TMCI

growth of $100 · dividends reinvested · last 2y
EPRX +162.7% (+62.1%/yr)TMCI -62.7% (-38.9%/yr)EPRX compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020252026$263$37
EPRX TMCI

EPRX vs TMCI: by the numbers

  • •TMCI is the larger company ($259M vs $259M market cap).
  • •Both run net losses; EPRX's is the smaller (0.00% vs -28.99% net margin).

Metrics side by side

Valuation

MetricEPRXTMCI
P/S ratioN/A1.26
P/B ratio2.553.83

Profitability

MetricEPRXTMCI
Gross margin0.00%79.45%
Operating margin0.00%-26.17%
Net margin0.00%-28.99%
ROE-38.33%-87.86%
ROIC-43.56%-37.64%

Growth (annualized)

MetricEPRXTMCI
Revenue CAGR (5Y)N/A21.44%
Total return CAGR (5Y)N/A-29.41%

Go deeper

Full EPRX analysisFull TMCI analysisInteractive comparison tool

Dig into the metrics

Eupraxia Pharmaceuticals ROETreace Medical Concepts ROEEupraxia Pharmaceuticals operating marginTreace Medical Concepts operating marginEupraxia Pharmaceuticals revenue growthTreace Medical Concepts revenue growthEupraxia Pharmaceuticals free cash flowTreace Medical Concepts free cash flow

Eupraxia Pharmaceuticals & Treace Medical Concepts appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.